These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 1882348)

  • 1. Lack of attenuation of valproic acid-induced effects by folinic acid in rat embryos in vitro.
    Hansen DK; Grafton TF
    Teratology; 1991 Jun; 43(6):575-82. PubMed ID: 1882348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Teratogenic effects of valproic acid and diphenylhydantoin on mouse embryos in culture.
    Bruckner A; Lee YJ; O'Shea KS; Henneberry RC
    Teratology; 1983 Feb; 27(1):29-42. PubMed ID: 6405496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid and pantothenic acid protection against valproic acid-induced neural tube defects in CD-1 mice.
    Dawson JE; Raymond AM; Winn LM
    Toxicol Appl Pharmacol; 2006 Mar; 211(2):124-32. PubMed ID: 16112698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of lithium carbonate on mouse and rat embryos in vitro.
    Hansen DK; Walker RC; Grafton TF
    Teratology; 1990 Feb; 41(2):155-60. PubMed ID: 2108509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glutathione status and the incidence of neural tube defects elicited by direct acting teratogens in vitro.
    Harris C; Stark KL; Juchau MR
    Teratology; 1988 Jun; 37(6):577-90. PubMed ID: 3135633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of supplemental folic acid on valproic acid-induced embryotoxicity and tissue zinc levels in vivo.
    Hansen DK; Grafton TF; Dial SL; Gehring TA; Siitonen PH
    Teratology; 1995 Nov; 52(5):277-85. PubMed ID: 8838251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Valproic acid increases formation of reactive oxygen species and induces apoptosis in postimplantation embryos: a role for oxidative stress in valproic acid-induced neural tube defects.
    Tung EW; Winn LM
    Mol Pharmacol; 2011 Dec; 80(6):979-87. PubMed ID: 21868484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphological differences elicited by two weak acids, retinoic and valproic, in rat embryos grown in vitro.
    Seegmiller RE; Harris C; Luchtel DL; Juchau MR
    Teratology; 1991 Feb; 43(2):133-50. PubMed ID: 2014479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Valproic acid in pregnancy: how much are we endangering the embryo and fetus?
    Ornoy A
    Reprod Toxicol; 2009 Jul; 28(1):1-10. PubMed ID: 19490988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of early-responsive genes correlated to valproic acid-induced neural tube defects in mice.
    Okada A; Kushima K; Aoki Y; Bialer M; Fujiwara M
    Birth Defects Res A Clin Mol Teratol; 2005 Apr; 73(4):229-38. PubMed ID: 15799026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of folinic acid and Vitamin B12 on ethanol-induced developmental toxicity in mouse.
    Xu Y; Li L; Zhang Z; Li Y
    Toxicol Lett; 2006 Dec; 167(3):167-72. PubMed ID: 17052868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pantothenic acid decreases valproic acid-induced neural tube defects in mice (I).
    Sato M; Shirota M; Nagao T
    Teratology; 1995 Sep; 52(3):143-8. PubMed ID: 8638254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Morphological changes induced by valproate and its administration concomitant with folinic acid or S-adenosylmethionine in pregnant rats].
    Ubeda-Martín N; Alonso-Aperte E; Achón M; Varela-Moreiras G; Puerta J; Pérez de Miguelsanz J
    Nutr Hosp; 1998; 13(1):41-9. PubMed ID: 9578686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydroxamic acid and fluorinated derivatives of valproic acid: anticonvulsant activity, neurotoxicity and teratogenicity.
    Gravemann U; Volland J; Nau H
    Neurotoxicol Teratol; 2008; 30(5):390-4. PubMed ID: 18455366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolite profiling of whole murine embryos reveals metabolic perturbations associated with maternal valproate-induced neural tube closure defects.
    Akimova D; Wlodarczyk BJ; Lin Y; Ross ME; Finnell RH; Chen Q; Gross SS
    Birth Defects Res; 2017 Jan; 109(2):106-119. PubMed ID: 27860192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of teratogenicity of trans-2-ene-valproic acid compared to valproic acid in rats.
    Vorhees CV; Acuff-Smith KD; Weisenburger WP; Minck DR; Berry JS; Setchell KD; Nau H
    Teratology; 1991 Jun; 43(6):583-90. PubMed ID: 1882349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strain differences in the teratogenicity induced by sodium valproate in cultured mouse embryos.
    Naruse I; Collins MD; Scott WJ
    Teratology; 1988 Jul; 38(1):87-96. PubMed ID: 3140405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of two validated in vitro tests to assess the embryotoxic potential of mycophenolic acid.
    Eckardt K; Stahlmann R
    Arch Toxicol; 2010 Jan; 84(1):37-43. PubMed ID: 19856175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic modifications in valproic acid-induced teratogenesis.
    Tung EW; Winn LM
    Toxicol Appl Pharmacol; 2010 Nov; 248(3):201-9. PubMed ID: 20705080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exencephaly and axial skeletal malformations induced by maternal administration of sodium valproate in the MF1 mouse.
    Padmanabhan R; Hameed MS
    J Craniofac Genet Dev Biol; 1994; 14(3):192-205. PubMed ID: 7852547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.